Tumor Budding as a Marker for Poor Prognosis and Epithelial–Mesenchymal Transition in Lung Cancer: A Systematic Review and Meta-Analysis
IntroductionCurrently, tumor budding (TB) is considered to predict the prognosis of patients. The prognostic significance of TB has also been explored in patients with lung cancer, but has not been fully clarified. In the present meta-analysis, we evaluated the prognostic significance, clinicopathol...
Main Authors: | Nishant Thakur, Muhammad Joan Ailia, Yosep Chong, Ok Ran Shin, Kwangil Yim |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.828999/full |
Similar Items
-
Role of epithelial mesenchymal transition (EMT) in pancreatic ductal adenocarcinoma (PDAC): is tumor budding the missing link?
by: Eva eKaramitopoulou
Published: (2013-09-01) -
Tumor budding of cervical squamous cell carcinoma: epithelial-mesenchymal transition-like cancer stem cells?
by: Shaoqiu Zheng, et al.
Published: (2022-07-01) -
Tumour budding is a novel marker in breast cancer: the clinical application and future prospects
by: Ting Huang, et al.
Published: (2022-12-01) -
Prognostic Value of Tumor Budding for Early Breast Cancer
by: Diogo J. Silva, et al.
Published: (2023-10-01) -
Significance of tumor budding in colorectal carcinoma – A tertiary care center study
by: Preeta Naik, et al.
Published: (2022-05-01)